Hormone therapy and coronary heart disease in young women

Menopause

Volumn 15, Issue 1, 2008, Pages 86-93

  Weiner, Mark G ^a   Barnhart, Kurt ^a   Xie, Dawei ^a   Tannen, Richard L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cohort studies; Coronary heart disease; Databases; Hormone therapy; Menopause; Randomized controlled trial

Indexed keywords

CONJUGATED ESTROGEN; MEDROXYPROGESTERONE; NORGESTREL;

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CLINICAL PRACTICE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; ELECTRONIC MEDICAL RECORD; FEMALE; HEART INFARCTION; HEART PROTECTION; HIP FRACTURE; HORMONAL THERAPY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; STROKE; UNITED KINGDOM; VENOUS THROMBOEMBOLISM;

AGE FACTORS; COHORT STUDIES; CORONARY DISEASE; DATABASES, FACTUAL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MENOPAUSE; MIDDLE AGED; MYOCARDIAL INFARCTION; NORGESTREL; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 38049068753     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3180413e45     Document Type: Article

References (23)

1. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in health postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
2. Grodstein F, Clarkson TB, Manson JE. Understanding the divergent data on postmenopausal hormone therapy. N Engl J Med 2003;348:645-650.
3. Michels KB, Manson JE. Postmenopausal hormone therapy: a reversal of fortune. Circulation 2003;107:1830-1833.
4. Creasman WT, Hoel D, DiSaia PJ. WHI: now that the dust has settled: a commentary. Am J Obstet Gynecol 2003;189:621-626.
5. Naftolin F, Taylor HS, Karas R, et al. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Fertil Steril 2004;81:1498-1501.
6. Tannen RL, Weiner MG, Xie D, Barnhart K. A simulation using data from a primary care practice database closely replicated the Women's Health Initiative Trial. J Clin Epidemiol. In press. Available as publish ahead of print at: http://www.sciencedirect.com/sciencejournal/08954356.
7. Stampfer M, Colditz G. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
8. Grady D, Rubin SB, Pettiti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-1037.
9. Barrett-Conner E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health 1998;19:55-72.
10. Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-461.
11. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfel MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000;133:933-941.
12. Hernan MA, Robins JM, Garcia-Rodriguez LA. Discussions on statistical issues arising in the Women's Health Initiative. Biometrics 2005;61:922-930.
13. Tannen RL, Weiner MG, Marcus SM. Simulation of the Syst-Eur randomized control trial using a primary care electronic medical record was feasible. J Clin Epidemiol 2006;59:254-264.
14. Gelfand JM, Margolis DJ, Dattani H. The UK General Practice Research Data Base. In: Strom BL, ed. Pharmacoepidemiology, 4th ed. New York, NY: John Wiley & Sons, 2005:337-346.
15. Raghunathan TE, Solenberger PW, Van Hoewyk J. IVEware: Imputation and Variance Estimation Software. Ann Arbor, MI: Institute for Social Research, University of Michigan, 1998.
16. Rubin D. Multiple Imputation for Non-response in Surveys. New York, NY: John Wiley & Sons, 1987.
17. Raghunathan TE, Lepkowski JM, Van Hoewyk J, Solenberger PW. A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Methodol 2001;27:85-95.
18. Rosenbaum P, Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41-55.
19. Rosenbaum P, Rubin D. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 1984;79:516-524.
20. D'Agostino RB, Rubin DB. Estimating and using propensity scores with partially missing data. J Am Stat Assoc 2000;95:749-759.
21. Manson JE, Martin KA. Clinical practice. Postmenopausal hormone replacement therapy. N Engl J Med 2001;354:34-40.
22. Weinstein M, Gorrindo T, Riley A, Mormino J, et al. Timing of menopause and patterns of menstrual bleeding. Am J Epidemiol 2003;158:782-791.
23. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004;350:991-1004.